Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$63,551,824
-$13,428,176 QoQ
Shares Held
1,642,166
-17.9% QoQ
Ownership
0.946%
of shares outstanding
% of Portfolio
1.93%
of 13F equity value
Holder Rank
#27
of 321 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Venrock Adviser, LLC holds $3,294,790,938 across 31 Biotechnology names. COGT ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
8,493,321 | $1,127,318,496 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
4,148,428 | $394,805,892 | |
| 3 | ERAS |
Erasca, Inc.
|
17,891,812 | $327,777,995 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
2,985,448 | $265,048,073 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,180,000 | $115,026,400 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
|
10,346,926 | $101,606,813 | |
| 7 | DMRA |
Damora Therapeutics, Inc.
|
3,603,595 | $93,729,505 | |
| 8 | SVRA |
Savara Inc
|
14,745,943 | $90,835,008 |
All Filings in COGT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,551,824 | 1,642,166 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $76,980,000 | 2,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $71,040,000 | 2,000,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $57,440,000 | 4,000,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $34,143,850 | 4,755,411 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $34,049,621 | 5,684,411 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $44,338,405 | 5,684,411 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $61,389,003 | 5,684,167 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $47,917,527 | 5,684,167 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $34,468,002 | 5,129,167 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $27,542,901 | 4,684,167 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $45,670,628 | 4,684,167 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $55,460,122 | 4,684,132 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $52,708,901 | 4,884,977 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $46,680,632 | 4,038,117 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $60,248,705 | 4,038,117 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $36,423,815 | 4,038,117 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $8,155,239 | 1,088,817 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $9,342,049 | 1,088,817 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,156,950 | 1,088,817 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,830,305 | 1,088,817 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,559,813 | 1,088,817 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $12,227,414 | 1,088,817 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 UMRX | — | 4,355,273 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||